Vendors DNAnexus and Saphetor hope to create a seamless platform for genome-based biomarker discovery and interpretation.
The companies will share bioinformatics and NGS expertise to speed the identification of diseases, accelerate drug discovery, and find "genomic shields."
The UCSF Helen Diller Family Comprehensive Cancer Center has installed GenomOncology's GO Clinical Workbench to support the institution's UCSF500 NGS panel.
A curation working group established a framework that considers the nature and strength of the available evidence when evaluating gene-disease associations.
Congenica will use the proceeds to establish its presence in the US and China, where it will court not only clinical genetics labs, but specialists, academics, biotech, and pharma.
Researchers identified and started analyzing thousands of non-repetitive, non-human reference genome sequences in individuals from Iceland.
In a new AMP working group project, labs can volunteer to compare their interpretation of challenging variants to help identify where and how the guidelines might be improved.
One deal will see Philips' solution used to improve cancer patient outcomes while the other will beef up its ability to interpret data from oncology tests.
The company said it will use the funds to complete and launch Mastermind, its flagship product for analyzing and interpreting variant data.
The partners will co-market the GenomOncology GO Clinical Workbench to interpret data generated using Fluidigm's Juno NGS library prep workflow.
The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.
Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.
In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.
Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.